Pediatric hematooncology in Poland

Q3 Medicine Acta Haematologica Polonica Pub Date : 2023-08-30 DOI:10.5603/ahp.96754
Krzysztof Czyżewski, J. Styczyński
{"title":"Pediatric hematooncology in Poland","authors":"Krzysztof Czyżewski, J. Styczyński","doi":"10.5603/ahp.96754","DOIUrl":null,"url":null,"abstract":"In Poland, the care of children with cancer and hematological diseases is provided within a single, very broad specialization in pediatric oncology and hematology. For almost all specialists, this is a second or subsequent specialization, while the specialization in pediatrics is a primary specialization. At present, 210 physicians have specialized in this niche field. There are 18 pediatric oncology and hematology centers in Poland. According to data from the National Consultant in Pediatric Oncology and Hematology, the total number of hospitalizations in pediatric oncohematology wards is about 31,000 annually. On an average working day in 18 pediatric oncology and hematology departments in Poland there are about 450 patients with malignant diseases (including patients after hematopoietic cell transplantation or cancer recurrence). Pediatric oncology is a discipline of rare diseases, as the incidence of pediatric malignancies is lower than 5 cases per 10,000 inhabitants annually [1]. The population of Poland in 2021 was 38.08 million, of whom 7.64 million (20.1%) were aged <18 years [2] (for comparison, in 1990 children accounted for 29% of the population of Poland). According to data from 2020, the number of new cases of cancers of the lymphatic, hematopoietic and related systems in Poland is c.8,100 per year, including c.450 in children (5.5%). In adults, leukemias and lymphomas each account for c.2% of all malignancies. 28% of all malignancies in children are leukemias (being the most common type of cancer) while lymphomas are c.13% [with a ratio of Hodgkin/non-Hodgkin lymphoma (HL/NHL) = 50%/50%] [3]. Myelodysplastic malignancies, chronic myeloproliferative neoplasms, and chronic myeloid leukemia in children are casuistic: for each of these, new diagnoses are fewer than 10 per year. The number of new histiocytoses in children is about 30 per year. Chronic lymphocytic leukemia and plasmocytic myeloma practically never occur in children. This issue of “Acta Haematologica Polonica” is focused on pediatric hematology and oncological hematology. Papers indicating current problems and trends in diagnostics and treatment in this field of medicine are presented, reflecting common problems for all hematologists [4–6].","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Haematologica Polonica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/ahp.96754","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

In Poland, the care of children with cancer and hematological diseases is provided within a single, very broad specialization in pediatric oncology and hematology. For almost all specialists, this is a second or subsequent specialization, while the specialization in pediatrics is a primary specialization. At present, 210 physicians have specialized in this niche field. There are 18 pediatric oncology and hematology centers in Poland. According to data from the National Consultant in Pediatric Oncology and Hematology, the total number of hospitalizations in pediatric oncohematology wards is about 31,000 annually. On an average working day in 18 pediatric oncology and hematology departments in Poland there are about 450 patients with malignant diseases (including patients after hematopoietic cell transplantation or cancer recurrence). Pediatric oncology is a discipline of rare diseases, as the incidence of pediatric malignancies is lower than 5 cases per 10,000 inhabitants annually [1]. The population of Poland in 2021 was 38.08 million, of whom 7.64 million (20.1%) were aged <18 years [2] (for comparison, in 1990 children accounted for 29% of the population of Poland). According to data from 2020, the number of new cases of cancers of the lymphatic, hematopoietic and related systems in Poland is c.8,100 per year, including c.450 in children (5.5%). In adults, leukemias and lymphomas each account for c.2% of all malignancies. 28% of all malignancies in children are leukemias (being the most common type of cancer) while lymphomas are c.13% [with a ratio of Hodgkin/non-Hodgkin lymphoma (HL/NHL) = 50%/50%] [3]. Myelodysplastic malignancies, chronic myeloproliferative neoplasms, and chronic myeloid leukemia in children are casuistic: for each of these, new diagnoses are fewer than 10 per year. The number of new histiocytoses in children is about 30 per year. Chronic lymphocytic leukemia and plasmocytic myeloma practically never occur in children. This issue of “Acta Haematologica Polonica” is focused on pediatric hematology and oncological hematology. Papers indicating current problems and trends in diagnostics and treatment in this field of medicine are presented, reflecting common problems for all hematologists [4–6].
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
波兰的儿科血液肿瘤学
在波兰,癌症和血液病儿童的护理由一个非常广泛的儿科肿瘤学和血液学专业提供。对于几乎所有的专家来说,这是第二个或随后的专业,而儿科专业是主要专业。目前,已有210名医生专门从事这一领域的工作。波兰有18个儿科肿瘤和血液学中心。根据国家儿科肿瘤和血液学顾问的数据,儿科肿瘤血液学病房每年的住院总人数约为31000人。波兰18个儿科肿瘤和血液科的平均工作日约有450名恶性疾病患者(包括造血细胞移植或癌症复发后的患者)。儿科肿瘤学是一门罕见病学科,因为儿科恶性肿瘤的发病率每年低于每10000名居民5例[1]。2021年波兰人口为3808万,其中764万(20.1%)年龄在18岁以下[2](相比之下,1990年儿童占波兰人口的29%)。根据2020年的数据,波兰每年新增淋巴、造血和相关系统癌症约8100例,其中儿童约450例(5.5%)。在成年人中,白血病和淋巴瘤各占所有恶性肿瘤的约2%。28%的儿童恶性肿瘤是白血病(是癌症最常见的类型),淋巴瘤约为13%[霍奇金/非霍奇金淋巴瘤(HL/NHL)的比例为50%/50%][3]。儿童骨髓增生异常恶性肿瘤、慢性骨髓增生性肿瘤和慢性髓系白血病是偶然的:每年新诊断的病例都不到10例。儿童新发组织细胞增多症的数量约为每年30例。慢性淋巴细胞白血病和浆细胞性骨髓瘤实际上从未发生在儿童身上。本期《波兰血液学杂志》主要关注儿科血液学和肿瘤学血液学。论文指出了该医学领域诊断和治疗的当前问题和趋势,反映了所有血液学家的常见问题[4-6]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Haematologica Polonica
Acta Haematologica Polonica Medicine-Oncology
CiteScore
1.60
自引率
0.00%
发文量
49
期刊最新文献
Treatment of primary central nervous system lymphoma (PCNSL) – single center experience. Evaluation of colonization and infection profile in allogeneic hematopoietic stem cell transplantation recipients Eltrombopag and high-dose dexamethasone as first-line treatment in children with newly diagnosed primary immune thrombocytopenia Treatment of resistant viral infections after allogeneic hematopoietic stem cell transplantation using virus-specific T cells Covid-19 in patients with haematological malignancies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1